drugset
Drugs / human menopause gonadotropin
last change Dec 2014 re-read 3 minutes ago

human menopause gonadotropin

also known as HMG

Protein / enzyme biologic

Developed for
infertility disorder
Investigated by
Center for Human Reproduction · Hospital de Clinicas de Porto Alegre

Trials 1

today NCT02412904 · Ph 4
20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02412904 Jan → Dec 2014 infertility disorder Hospital de Clinicas de Porto Alegre Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as human menopause gonadotropin “To compare embryonic quality and other clinical outcomes when using human menopause gonadotropin (hMG) or recombinant follicle stimulating hormone (rFSH) to the ovarian...” NCT02412904 ↗
Known as HMG ClinicalTrials.gov intervention name — accepted as the source's own label NCT02412904 ↗
Modality Protein / enzyme biologic “human menopause gonadotropin (hMG)” NCT02412904 ↗